Abstract |
Nine patients with renal cell carcinoma and severe hematuria were palliatively treated with a new type of angioocclusion: the concept of capillary embolization. The so-called occlusion gel Ethibloc was used as embolizing agent. Each patient was followed up until death or for at least 4 years. All patients had a stage T3 or T4 tumor, 3 patients had metastases to multiple organs, 3 had lung metastases, and 3 were free of metastatic disease. In all cases, very high volumes (14-40 ml) of the embolizing agent were necessary to achieve total occlusion of the entire arterial compartment. Patients without metastatic disease had a mean survival time of 6 years and 4 months, all of them without signs of malignant disease. Patients with metastases had a mean survival time of 3 years. Compared with the natural history of renal cell carcinoma treated otherwise, this represents a substantial prolongation of survival time. Contrary to other angioocclusive treatment modalities, the concept of capillary occlusion with Ethibloc seems to achieve total tumor destruction.
|
Authors | G W Kauffmann, G M Richter, R Rohrbach, W Wenz |
Journal | Cardiovascular and interventional radiology
(Cardiovasc Intervent Radiol)
1989 Jan-Feb
Vol. 12
Issue 1
Pg. 22-8
ISSN: 0174-1551 [Print] United States |
PMID | 2496923
(Publication Type: Journal Article)
|
Chemical References |
- Drug Combinations
- Fatty Acids
- Propylene Glycols
- Proteins
- Diatrizoate
- Zein
- alcoholic prolamine solution
|
Topics |
- Capillaries
- Carcinoma, Renal Cell
(diagnostic imaging, mortality, therapy)
- Diatrizoate
- Drug Combinations
- Embolization, Therapeutic
(methods)
- Fatty Acids
- Humans
- Kidney
(diagnostic imaging)
- Kidney Neoplasms
(diagnostic imaging, mortality, therapy)
- Prognosis
- Propylene Glycols
- Proteins
(therapeutic use)
- Tomography, X-Ray Computed
- Zein
|